medigraphic.com
ISSN 1527-3172 (Digital)

2008, Número 2

<< Anterior Siguiente >>

MEDICC Review 2008; 10 (2)


Association between blood lipids and types of stroke

González GS, Fernández CO, Fernández CR, Menéndez SC, Maza J, González-Quevedo MA, Buergo ZMÁ

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 27-32
Archivo PDF: 1317.40 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109(23 Sup 1):III15-9.

  2. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647-53.

  3. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD for the MRFIT Research Group. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–10.

  4. Amarenco P, Lavallee P, Touboul JP. Stroke prevention, blood cholesterol, and statins. Lancet Neurol. 2004;3:271-8.

  5. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549- 59.

  6. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23 Suppl 1):III39-43.

  7. Zhou J, Zhang M, Li XM. Comparative study of serum lipids and serum lipoprotein spectrum in patients with cerebrovascular diseases. Di Yi Jun Yi Da Xue Xue Bao. 2003;23(3):262-4.

  8. López-Virella MF. Comparison of 3 methods of selective isolation for HDL determination. Clin Chem. 1977;23:882.

  9. Díez-Tejedor E, Del Brutto O, Álvarez-Sabín J, Muñoz M, Abiusi G. Clasificación de las enfermedades cerebrovasculares. Sociedad Iberoamericana de Enfermedades Cerebrovasculares. Rev Neurol. 2001;33(5):455-64.

  10. Informática Médica. Bioestadística Tomo II. CECAM. La Habana: Editorial Ciencias Médicas, 2004.

  11. González S, Fernández O, González A, Fernández R, Molina L, Valdés V. Las alteraciones lipídicas en el infarto cerebral. Rev Inv Biomed. 2001;21(3):149-154.

  12. Xu H, Yang Q, Tang B. Studies on stroke and blood lipid level. Zhonghua Yu Fang Yi Xue Za Zhi. 1998;32(6):366-8.

  13. Peng D, Zhao S. Serum lipids, lipoprotein and stroke. Hunan Yi Ke Da Xue Xue Bao. 1999;24(2):167-70.

  14. Liu XN, Gao Y, Ye J, Wang DW, Liao YH, Ma AQ, et al. Association of small, dense low density lipoprotein with stroke. Zhonghua Yi Xue Za Zhi. 2003;83(22):1939-42.

  15. Denti L, Cecchetti A, Annoni V, Merli MF, Ablondi F, Valenti G. The role of lipid profile in determining the risk of ischemic stroke in the elderly: a case-control study. Arch Gerontol Geriatr. 2003;37(1):51-62.

  16. Horenstein RB, Smith DE, Mosca L. Cholesterol predicts stroke mortality in the Women’s Pooling Project. Stroke. 2002;33(7):1863-8.

  17. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in Stroke Prevention and Carotid Atherosclerosis. Systematic Review and Up-to-Date Meta-Analysis. Stroke. 2004;35(12):2902-9.

  18. Gresser U, Gathof BS. Atorvastatin: Gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. Eur J Med Res. 2004;9(1):1-17.

  19. Sasaki J, Arakawa K, Iwashita M, Matsushita Y, Kono S. Kyushu Lipid Intervention Study (KLIS) Group. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study. Jpn Circ J. 2003;67(6):473-8.

  20. Wierzbicki AS, Mikhailidis DP, Wray R, Schacter M, Cramb R, Simpson WG, et al. Statin-fibrate combination: therapy for hyperlipidemia: a review. Curr Med Res Opin. 2003;19(3):155-68.

  21. Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8,586 men from the Israeli Ischemic Heart Disease Study. Stroke. 1997;28(1):83-7.

  22. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, et al. Oyabe Study. Highdensity lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke. 2003;34(4):863-8.

  23. Curb JD, Abbott RD, Rodriguez BL, Masaki KH, Chen R, Popper JS, et al. High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu Heart Program. Am J Epidemiol. 2004;160(2):150-7

  24. Morales A, Morera-Guitart J, Bautista-Prados J, Clar C, Herruzo E, Mas G, et al. Diagnóstico etiológico del infarto cerebral en el hospital comarcal. Rev Neurol. 2003;36(5):405-11.

  25. González S, Fernández O, González A, Fernández R, Valdés M. Papel de los lípidos sanguíneos en las distintas etiologías del infarto cerebral. Rev Neurol. 2003;36(7):625-8.

  26. Bowman TS, Sesso HD, Ma J, Kurth T, Kase CI, Stampfer MJ, et al. Cholesterol and the risk of ischemic stroke. Stroke. 2003;34(12):2930-4.

  27. Laloux P, Galanti L, Jamart J. Lipids in ischemic stroke subtypes. Acta Neurol Belg. 2004;104(1):13-9.

  28. Pines A, Bornstein NM, Shapira I. Menopause and ischemic stroke: basic clinical and epidemiological considerations. The role of hormone replacement. Hum Reprod Update. 2002;8(2):161- 168.

  29. Okumura K, Iseki K, Wakugami K, Kimura Y, Muratani H, Ikemiya Y, et al. Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. Jpn Circ J. 1999;63(1):53-8.

  30. Iribarren C, Jacobs DR, Sadler M, Claxton AJ, Sidney S. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke. 1996;27(11):1993-8.

  31. Amarenco P, Steg PG. The paradox of cholesterol and stroke. Lancet. 2007;370:1803-1804.




2020     |     www.medigraphic.com